We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oklo Advances Groves-1 Reactor Into Research and Testing Phase
Read MoreHide Full Article
Key Takeaways
DOE clearance lets Oklo move Groves-1 beyond demonstration into unrestricted research and testing operations.
Groves-1 will evaluate control rod drives, refine reactor interfaces and train staff for future deployments.
Insights from Groves-1 could bolster Aurora reactors and Groves-2 Forge's planned lutetium-177 production.
Oklo Inc. (OKLO - Free Report) is preparing to expand the capabilities of its Groves Isotope Test Reactor (Groves-1) after receiving clearance from the U.S. Department of Energy (DOE) to begin unrestricted operations. The approval marks an important milestone for the advanced nuclear technology company, allowing the facility to move beyond its initial reactor demonstration phase and focus on research, equipment testing and workforce training.
The reactor, which achieved first criticality in August 2026 under the DOE's Reactor Pilot Program (RPP), became the first facility to reach this milestone under the program on private land. Its successful development has also demonstrated Oklo's ability to take a nuclear project from initial construction to operational readiness in less than a year.
Groves-1 to Strengthen Oklo's Reactor Development Capabilities
With the final operational hold point cleared, Oklo plans to use Groves-1 as a platform to evaluate technologies and operating procedures that could support its future isotope reactors and Aurora fast fission powerhouses. The experience gained during the reactor's initial deployment is expected to help the company establish the technical systems, operational processes and workforce capabilities required for additional nuclear projects.
Oklo has already started incorporating practical operating experience into its development process. During a recent reactor startup, operators used eye-tracking glasses to monitor their visual attention and identify areas for improvement in the human-machine interface. The information gathered could help the company refine reactor controls and incorporate better design features into future facilities.
Groves-1 will also support personnel training and qualification for upcoming reactor deployments. In addition, Oklo intends to continue evaluating equipment performance, particularly the reliability and functioning of control rod drive mechanisms.
Testing Activities Could Support Broader Nuclear Applications
Beyond workforce development and equipment evaluations, Groves-1 is expected to play an important role in advancing Oklo's isotope production capabilities and engineering models. The facility will conduct criticality and reactivity benchmarking activities to generate data that could improve reactor design and performance assessments.
These evaluations may also have applications beyond Oklo's own reactor projects. The company expects the resulting insights to potentially support both small and large light water reactors, including the broader existing light water reactor fleet. Better benchmarking data could help improve fuel performance and increase power output across these reactor systems.
The company highlighted the importance of taking Groves-1 from a greenfield site to criticality in less than a year. The company now intends to build on this achievement through continued reactor operations, testing and practical learning to develop the people and processes needed for its expanding project pipeline.
Groves-1 Experience to Inform Upcoming Isotope Projects
The operational experience accumulated at Groves-1 will also contribute to the development of Oklo's next major isotope initiative, Groves-2 Forge. Selected under the DOE's Nuclear Energy Launch Pad initiative, the planned pilot facility is designed to bring together different stages of the isotope production value chain.
Groves-2 Forge will combine reactor irradiation with hot-cell processing capabilities, covering activities such as isotope separation, product recovery, packaging and transportation. Its initial focus will be lutetium-177, an isotope used in targeted cancer treatments.
By advancing Groves-1 into unrestricted operations, Oklo is gaining an opportunity to test technologies, strengthen its technical workforce and gather operational insights that could support its future nuclear and isotope projects. The experience could prove valuable as the company moves toward developing an integrated isotope production platform and expanding its Aurora reactor ambitions.
OKLO’s Zacks Rank & Key Picks
Oklo is an advanced nuclear energy company focused on developing, owning and operating small nuclear power plants under its Aurora product line. Currently, OKLO has a Zacks Rank #3 (Hold).
North Carolina-based Curtiss-Wright is a diversified multinational company that designs and overhauls precision components. The Zacks Consensus Estimate for CW’s 2026 earnings indicates 17.2% year-over-year growth.
GE Vernova is an energy company that includes Power, Wind and Electrification segments and is supported by its accelerator businesses of Advanced Research, Consulting Services and Financial Services. The Zacks Consensus Estimate for GEV’s 2026 earnings indicates 79.5% year-over-year growth.
NexGen Energy focuses on the acquisition, exploration and development of Canadian uranium projects. The Zacks Consensus Estimate for NXE’s 2026 earnings indicates 50% year-over-year growth.
View the Zacks #1 Rank List
Image: Bigstock
Oklo Advances Groves-1 Reactor Into Research and Testing Phase
Key Takeaways
Oklo Inc. (OKLO - Free Report) is preparing to expand the capabilities of its Groves Isotope Test Reactor (Groves-1) after receiving clearance from the U.S. Department of Energy (DOE) to begin unrestricted operations. The approval marks an important milestone for the advanced nuclear technology company, allowing the facility to move beyond its initial reactor demonstration phase and focus on research, equipment testing and workforce training.
The reactor, which achieved first criticality in August 2026 under the DOE's Reactor Pilot Program (RPP), became the first facility to reach this milestone under the program on private land. Its successful development has also demonstrated Oklo's ability to take a nuclear project from initial construction to operational readiness in less than a year.
Groves-1 to Strengthen Oklo's Reactor Development Capabilities
With the final operational hold point cleared, Oklo plans to use Groves-1 as a platform to evaluate technologies and operating procedures that could support its future isotope reactors and Aurora fast fission powerhouses. The experience gained during the reactor's initial deployment is expected to help the company establish the technical systems, operational processes and workforce capabilities required for additional nuclear projects.
Oklo has already started incorporating practical operating experience into its development process. During a recent reactor startup, operators used eye-tracking glasses to monitor their visual attention and identify areas for improvement in the human-machine interface. The information gathered could help the company refine reactor controls and incorporate better design features into future facilities.
Groves-1 will also support personnel training and qualification for upcoming reactor deployments. In addition, Oklo intends to continue evaluating equipment performance, particularly the reliability and functioning of control rod drive mechanisms.
Testing Activities Could Support Broader Nuclear Applications
Beyond workforce development and equipment evaluations, Groves-1 is expected to play an important role in advancing Oklo's isotope production capabilities and engineering models. The facility will conduct criticality and reactivity benchmarking activities to generate data that could improve reactor design and performance assessments.
These evaluations may also have applications beyond Oklo's own reactor projects. The company expects the resulting insights to potentially support both small and large light water reactors, including the broader existing light water reactor fleet. Better benchmarking data could help improve fuel performance and increase power output across these reactor systems.
The company highlighted the importance of taking Groves-1 from a greenfield site to criticality in less than a year. The company now intends to build on this achievement through continued reactor operations, testing and practical learning to develop the people and processes needed for its expanding project pipeline.
Groves-1 Experience to Inform Upcoming Isotope Projects
The operational experience accumulated at Groves-1 will also contribute to the development of Oklo's next major isotope initiative, Groves-2 Forge. Selected under the DOE's Nuclear Energy Launch Pad initiative, the planned pilot facility is designed to bring together different stages of the isotope production value chain.
Groves-2 Forge will combine reactor irradiation with hot-cell processing capabilities, covering activities such as isotope separation, product recovery, packaging and transportation. Its initial focus will be lutetium-177, an isotope used in targeted cancer treatments.
By advancing Groves-1 into unrestricted operations, Oklo is gaining an opportunity to test technologies, strengthen its technical workforce and gather operational insights that could support its future nuclear and isotope projects. The experience could prove valuable as the company moves toward developing an integrated isotope production platform and expanding its Aurora reactor ambitions.
OKLO’s Zacks Rank & Key Picks
Oklo is an advanced nuclear energy company focused on developing, owning and operating small nuclear power plants under its Aurora product line. Currently, OKLO has a Zacks Rank #3 (Hold).
Investors interested in the nuclear energy sector may consider some top-ranked stocks like Curtiss-Wright Corporation (CW - Free Report) , GE Vernova Inc. (GEV - Free Report) and NexGen Energy Ltd. (NXE - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
North Carolina-based Curtiss-Wright is a diversified multinational company that designs and overhauls precision components. The Zacks Consensus Estimate for CW’s 2026 earnings indicates 17.2% year-over-year growth.
GE Vernova is an energy company that includes Power, Wind and Electrification segments and is supported by its accelerator businesses of Advanced Research, Consulting Services and Financial Services. The Zacks Consensus Estimate for GEV’s 2026 earnings indicates 79.5% year-over-year growth.
NexGen Energy focuses on the acquisition, exploration and development of Canadian uranium projects. The Zacks Consensus Estimate for NXE’s 2026 earnings indicates 50% year-over-year growth.